BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 14200096)

  • 1. RELATIONSHIP OF THE ADENOVIRUS ERYTHROCYTE-RECEPTOR-MODIFYING FACTOR TO THE TYPE-SPECIFIC COMPLEMENT-FIXING ANTIGEN.
    KASEL JA; HUBER M
    Proc Soc Exp Biol Med; 1964 May; 116():16-8. PubMed ID: 14200096
    [No Abstract]   [Full Text] [Related]  

  • 2. HUMAN ADENOVIRUS TYPE 31. A NEW SEROTYPE WITH ONCOGENIC PROPERTIES.
    PEREIRA MS; PERIERA HG; CLARKE SK
    Lancet; 1965 Jan; 1(7375):21-3. PubMed ID: 14246675
    [No Abstract]   [Full Text] [Related]  

  • 3. PRODUCTION AND STANDARDIZATION OF ADENOVIRUS TYPES 1 TO 18 REFERENCE ANTISERA.
    RAFAJKO RR
    Am J Hyg; 1964 May; 79():310-9. PubMed ID: 14159950
    [No Abstract]   [Full Text] [Related]  

  • 4. STUDIES ON ADENOVIRUS-12. I. QUANTITATIVE CORRELATIONS BETWEEN SOME PHYSICAL, ANTIGENIC AND INFECTIOUS PROPERTIES.
    SMITH KO
    J Immunol; 1965 Jun; 94():976-89. PubMed ID: 14321442
    [No Abstract]   [Full Text] [Related]  

  • 5. IN VITRO TRANSFORMATION OF HAMSTER KIDNEY CELLS BY HUMAN ADENOVIRUS TYPE 12.
    MCBRIDE WD; WIENER A
    Proc Soc Exp Biol Med; 1964 Apr; 115():870-4. PubMed ID: 14166590
    [No Abstract]   [Full Text] [Related]  

  • 6. [COMPARATIVE EVOLUTION OF HEMAGGLUTINATION-INHIBITING, COMPLEMENT-FIXING AND NEUTRALIZING ANTIBODIES DURING AN EPIDEMIC DUE TO ADENOVIRUS 7A].
    HENRY M; SOHIER R; CHARDONNET Y
    Ann Inst Pasteur (Paris); 1965 Feb; 108():180-95. PubMed ID: 14308777
    [No Abstract]   [Full Text] [Related]  

  • 7. PRODUCTION OF SV-40 COMPLEMENT-FIXING ANTIGEN.
    SCHELL KR
    Nature; 1964 Jul; 203():417-8. PubMed ID: 14197394
    [No Abstract]   [Full Text] [Related]  

  • 8. THE INCORPORATION OF SV40 MATERIAL INTO ADENOVIRUS 7 AS MEASURED BY INTRANUCLEAR SYNTHESIS OF SV40 TUMOR ANTIGEN.
    RAPP F; MELNICK JL; BUTEL JS; KITAHARA T
    Proc Natl Acad Sci U S A; 1964 Dec; 52(6):1348-52. PubMed ID: 14243507
    [No Abstract]   [Full Text] [Related]  

  • 9. SPECIFIC ADENOVIRUS COMPLEMENT-FIXING ANTIGENS IN VIRUS-FREE HAMSTER AND RAT TUMORS.
    HUEBNER RJ; ROWE WP; TURNER HC; LANE WT
    Proc Natl Acad Sci U S A; 1963 Aug; 50(2):379-89. PubMed ID: 14060660
    [No Abstract]   [Full Text] [Related]  

  • 10. PRODUCTION OF "TUMOR-SPECIFIC" ANTIGENS BY ONCOGENIC VIRUSES DURING ACUTE CYTOLYTIC INFECTIONS.
    HOGGAN MD; ROWE WP; BLACK PH; HUEBNER RJ
    Proc Natl Acad Sci U S A; 1965 Jan; 53(1):12-9. PubMed ID: 14283190
    [No Abstract]   [Full Text] [Related]  

  • 11. SPECIFIC COMPLEMENT-FIXING TUMOR ANTIGEN IN SV40-TRANSFORMED HUMAN CELLS.
    HABEL K; JENSEN F; PAGANO JS; KOPROWSKI H
    Proc Soc Exp Biol Med; 1965 Jan; 118():4-9. PubMed ID: 14254582
    [No Abstract]   [Full Text] [Related]  

  • 12. PRODUCTION OF SPECIFIC NEUTRALIZING ANTIBODY WITH SOLUBLE ANTIGENS OF TYPE 5 ADENOVIRUS.
    WILCOX WC; GINSBERG HS
    Proc Soc Exp Biol Med; 1963 Oct; 114():37-42. PubMed ID: 14076907
    [No Abstract]   [Full Text] [Related]  

  • 13. STUDIES ON THE AETIOLOGY OF EPIDEMIC KERATOCONJUNCTIVITIS OBSERVED IN BUDAPEST DURING WINTER, 1961--1962.
    NASZ I; KULCSAR G; DAN P; LENGYEL A; CSERBA I
    Acta Microbiol Acad Sci Hung; 1963; 10():35-40. PubMed ID: 14043494
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on the serologic identification of adenovirus. I. Comparison of the hemagglutination, conglutinating complement adsorption, and complement fixation tests.
    PRIER JE; LEBEAU RW
    J Lab Clin Med; 1958 Mar; 51(3):495-500. PubMed ID: 13514265
    [No Abstract]   [Full Text] [Related]  

  • 15. PATTERNS OF ADENOVIRUS INFECTIONS IN MARINE CORPS PERSONNEL. II. LONGITUDINAL STUDY OF SUCCESSIVE ADVANCED RECRUIT TRAINING COMPANIES.
    FORSYTH BR; BLOOM HH; JOHNSON KM; CHANOCK RM
    Am J Hyg; 1964 Nov; 80():343-55. PubMed ID: 14225925
    [No Abstract]   [Full Text] [Related]  

  • 16. A HOSPITAL EPIDEMIC OF KERATOCONJUNCTIVITIS CAUSED BY ADENOVIRUS TYPE 7 IN HELSINKI.
    TOMMILA V; LAPINLEIMU K
    Acta Ophthalmol (Copenh); 1965; 43():294-8. PubMed ID: 14293652
    [No Abstract]   [Full Text] [Related]  

  • 17. A COMPLEMENT-FIXING ANTIGEN FOR VARICELLA-ZOSTER DERIVED FROM INFECTED CULTURES OF HUMAN FETAL DIPLOID CELLS.
    SCHMIDT NJ; LENNETTE EH; SHON CW; SHINOMOTO TT
    Proc Soc Exp Biol Med; 1964 May; 116():144-9. PubMed ID: 14200088
    [No Abstract]   [Full Text] [Related]  

  • 18. SPECIFIC COMPLEMENT-FIXING TUMOR ANTIGENS IN HUMAN CELLS MORPHOLOGICALLY TRANSFORMED BY SV40 VIRUS.
    SABIN AB; SHEIN HM; KOCH MA; ENDERS JF
    Proc Natl Acad Sci U S A; 1964 Dec; 52(6):1316-8. PubMed ID: 14243502
    [No Abstract]   [Full Text] [Related]  

  • 19. AN INCOMPLETE CYCLE OF ADENOVIRUS TYPE 4 MULTIPLICATION IN CANINE CELL CULTURES AND IN DOGS.
    CARMICHAEL LE
    Am J Vet Res; 1965 Jan; 26():15-23. PubMed ID: 14266923
    [No Abstract]   [Full Text] [Related]  

  • 20. CHARACTERIZATION OF AGENTS ISOLATED FROM MARKET CHICKENS IN A QUEST FOR ENTERIC VIRUSES.
    CLEMMER DI
    J Infect Dis; 1964 Dec; 114():386-400. PubMed ID: 14233129
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.